Back to Search
JOSEPH FRIEDMAN
Behavior Analyst
NPI: 1144020264Individual
Specialties, Licenses & Credentials
Clinical Trials (3)
3
Linked Trials
0
Recruiting
1
With Results
Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
NCT00488163COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
NCT00158223COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
The Effect of Rasagiline on Cognition in Parkinson's Disease
NCT01382342COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (2)
Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy.
PMID 21346734·Neuropsychopharmacology·2011
2-rct
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
PMID 12431845·Neuropsychopharmacology·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 833 CENTRAL AVE APT 4K
FAR ROCKAWAY, NY 11691 - Phone
- (917) 538-8400
Quick Facts
- NPI
- 1144020264
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 3
- Publications
- 2
Are you this provider?
Claim Your Profile